Choen, Sangkyung
Kent, Michael S.
Loucks, F. Alexandra
Winger, Jonathan A.
Zwingenberger, Allison L.
Funding for this research was provided by:
National Institutes of Health (R01CA20472)
National Cancer Institute (NCI P30CA093373)
Article History
Received: 11 December 2023
Accepted: 6 May 2024
First Online: 13 May 2024
Declarations
:
: We confirm that all experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) and Veterinary Clinical Trial Review Board of the University of California Davis (#20831). We confirm that all procedures were carried out in accordance with the ARRIVE criteria. An informed consent from the owner(s) to use the animals in our study was obtained.
: Not applicable.
: JAW and FAL are employees of Omniox, Inc. and hold shares/options in Omniox, Inc. JAW is eligible to receive a portion of royalties from patents relating to uses of OMX products. The other authors declare no competing interests.